TY - JOUR
KW - *Acquired Immune Deficiency Syndrome
KW - *Opiates
KW - *Patients
KW - *Values
KW - 6129: addiction
KW - article
KW - buprenorphine/naloxone, raltegravir, pharmacokinetics, HIV/AIDS, substance abuse
AU - Douglas Bruce
AU - David E. Moody
AU - Diane Chodkowski
AU - Laurie Andrews
AU - Wenfang B. Fang
AU - Jerdravee Morrison
AU - Theresa L. Parsons
AU - Gerald H. Friedland
A1 - 
BT - The American Journal of Drug and Alcohol Abuse
C5 - Opioids & Substance Use
CP - 2
IS - 2
JF - The American Journal of Drug and Alcohol Abuse
PB - Taylor & Francis Inc., Philadelphia, PA
PY - 2013
SN - 0095-2990, 0095-2990
SP - 80
EP - 85
EP - 
T1 - Pharmacokinetic Interactions between Buprenorphine/Naloxone and Raltegravir in Subjects Receiving Chronic Buprenorphine/Naloxone Treatment
T2 - The American Journal of Drug and Alcohol Abuse
TI - Pharmacokinetic Interactions between Buprenorphine/Naloxone and Raltegravir in Subjects Receiving Chronic Buprenorphine/Naloxone Treatment
U1 - Opioids & Substance Use
UR - http://search.proquest.com/docview/1364705614?accountid=28100
VL - 39
VO - 0095-2990, 0095-2990
Y1 - 2013
ER -